Micafungin Anti-Fungal Prophylaxis in Immunocompromised Pediatric Patients: A Pharmacokinetic Study
Phase of Trial: Phase I
Latest Information Update: 29 May 2018
Price : $35 *
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- 21 May 2018 Status changed from active, no longer recruiting to discontinued.
- 05 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Mar 2014 New trial record